Related Experiment Videos
Hypertrophic cardiomyopathy in infants of diabetic mothers: an update
1Department of Pediatrics, Oregon Health Sciences University, Portland 97201.
Insights
Infants of diabetic mothers (IDMs) may develop hypertrophic cardiomyopathy. Careful diabetic control during pregnancy significantly reduces the severity of this condition in newborns, preventing heart failure symptoms.
Area of Science:
- Cardiology
- Neonatology
- Endocrinology
Background:
- Infants of diabetic mothers (IDMs) are at increased risk for hypertrophic cardiomyopathy.
- Cardiomyopathy severity ranges from asymptomatic to severe congestive heart failure.
Purpose of the Study:
- Review pathophysiologic mechanisms of IDM cardiomyopathy.
- Discuss diagnostic tests, particularly echocardiography.
- Explore mechanisms leading to congestive heart failure.
Main Methods:
- Review of pathophysiologic mechanisms.
- Discussion of diagnostic modalities.
- Analysis of a prospective study on diabetic pregnancies with controlled glucose levels.
Main Results:
- IDMs in the prospective study showed mild generalized hypertrophy compared to controls.
- None of the infants in the study developed symptomatic congestive heart failure.
- Controlled diabetic management during pregnancy correlated with reduced cardiomyopathy severity.
Conclusions:
- Careful diabetic management in pregnancy is crucial for mitigating hypertrophic cardiomyopathy in IDMs.
- Maintaining glycemic control reduces the risk of severe cardiac outcomes in infants of diabetic mothers.
- Echocardiography is a key diagnostic tool for IDM cardiomyopathy.
Abstract:
Infants of diabetic mothers (IDMs) are at known risk for developing a hypertrophic type of cardiomyopathy. The severity of IDM cardiomyopathy can vary from an incidental finding on echocardiography to an infant with severe symptoms of congestive heart failure. The purpose of this article is to review the pathophysiologic mechanisms involved in the development of cardiomyopathy in IDMs and to discuss the diagnostic tests utilized in making the diagnosis (especially echocardiography) and the potential mechanisms that may result in congestive heart failure. This report will conclude with a review of a 2 1/2 year prospective study of diabetic women who had carefully maintained diabetic control during pregnancy. Although the IDMs in this study continued to have mild evidence of generalized hypertrophy when compared with control newborn infants, none developed symptoms of congestive heart failure. These data support the contention that careful diabetic management in pregnancy reduces the severity of hypertrophic cardiomyopathy in IDMs.